Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Public biotech 2008—the numbers

Nature Biotechnology volume 27, pages 710–721 (2009)Cite this article

The sour global economy has left many small public firms gasping for air.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Public biotech company revenue, R&D spending, profits and number of employees by market cap.
Figure 2: Global biotech industry financing.
Figure 3: Global biotech initial public offerings.
Figure 4: Public biotech companies by geographical location.

Author information

Authors and Affiliations

  1. Data retrieval for this article was by Ernst & Young (Boston) and Riku Lähteenmäki, a freelance writer in Turku, Finland. Laura DeFrancesco, senior editor of Nature Biotechnology, provided the analysis. John Hodgson is editor-at-large and Brady Huggett business editor at Nature Biotechnology.,

    Brady Huggett, John Hodgson & Riku Lähteenmäki

Authors
  1. Brady Huggett
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John Hodgson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Riku Lähteenmäki
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huggett, B., Hodgson, J. & Lähteenmäki, R. Public biotech 2008—the numbers. Nat Biotechnol 27, 710–721 (2009). https://doi.org/10.1038/nbt0809-710

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0809-710

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing